Compounds > troleandomycin
Page last updated: 2024-09-05

troleandomycin and desloratadine

troleandomycin has been researched along with desloratadine in 1 studies

Compound Research Comparison

Studies
(troleandomycin)		Trials
(troleandomycin)		Recent Studies (post-2010)
(troleandomycin)		Studies
(desloratadine)		Trials
(desloratadine)		Recent Studies (post-2010) (desloratadine)
5692623465146166

Protein Interaction Comparison

ProteinTaxonomytroleandomycin (IC50)desloratadine (IC50)
5-hydroxytryptamine receptor 4Cavia porcellus (domestic guinea pig)0.03
Aldo-keto reductase family 1 member B1Rattus norvegicus (Norway rat)1.116
Muscarinic acetylcholine receptor M2Homo sapiens (human)0.107
Muscarinic acetylcholine receptor M4Homo sapiens (human)0.339
Muscarinic acetylcholine receptor M5Homo sapiens (human)0.292
Muscarinic acetylcholine receptor M1Homo sapiens (human)0.267
Alpha-2B adrenergic receptorHomo sapiens (human)2.146
Muscarinic acetylcholine receptor M3Homo sapiens (human)0.446
Sodium-dependent noradrenaline transporter Homo sapiens (human)1.116
Histamine H2 receptorHomo sapiens (human)1.099
5-hydroxytryptamine receptor 2AHomo sapiens (human)0.033
5-hydroxytryptamine receptor 2CHomo sapiens (human)0.03
Sodium-dependent serotonin transporterHomo sapiens (human)0.23
Histamine H1 receptorHomo sapiens (human)0.0059
D(3) dopamine receptorHomo sapiens (human)1.906
5-hydroxytryptamine receptor 2BHomo sapiens (human)0.043
5-hydroxytryptamine receptor 6Homo sapiens (human)2.171
Sodium-dependent dopamine transporter Homo sapiens (human)3.879

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cayen, MN; Chen, KJ; Clement, RP; Huie, K; Snow, M; Yumibe, N1

Other Studies

1 other study(ies) available for troleandomycin and desloratadine

ArticleYear
Identification of human liver cytochrome P450 enzymes that metabolize the nonsedating antihistamine loratadine. Formation of descarboethoxyloratadine by CYP3A4 and CYP2D6.
    Biochemical pharmacology, 1996, Jan-26, Volume: 51, Issue:2

    Topics: Anti-Bacterial Agents; Antifungal Agents; Antimalarials; Binding Sites; Biotransformation; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Histamine H1 Antagonists; Humans; In Vitro Techniques; Ketoconazole; Loratadine; Microsomes, Liver; Mixed Function Oxygenases; Models, Molecular; Oxidation-Reduction; Piperidines; Pyridines; Quinidine; Recombinant Proteins; Substrate Specificity; Troleandomycin

1996